Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Hamid Zahednasab

Showing results (1-10 of 44) with videos related to

Pageof 5
Sort By:
Neurology|July 3, 2013
Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?Hamid Zahednasab
Neurology|November 7, 2012
Anti-JC Virus Antibodies in a Large German Natalizumab-Treated MS CohortHamid Zahednasab
Journal of Neuroimmunology|February 10, 2016
The correlation of HLA-G with multiple sclerosisHamid Zahednasab, Sajad Karampoor
International Journal of Biological Macromolecules|October 8, 2025
Molecular interplay between oxidative and endoplasmic reticulum stress in multiple sclerosisMaryam Kamarehei, Hamid Zahednasab
Neuropeptides|June 22, 2025
Neuroprotective effect of Ac-SDKP peptide in SH-SY5Y cells and rat model of Parkinson's disease against 6-OHDA-induced oxidative stress and ER stressMaryam Kamarehei, Hamid Zahednasab
Gene|July 12, 2014
The role of miR-326 and miR-26a in MS disease activityHamid Zahednasab, Mohammad Balood
Annals of Neurology|March 19, 2011
Interferon-beta and toll-like receptor-9 processingHamid Zahednasab, Seyed Amir Bahreini
Journal of the Neurological Sciences|March 16, 2010
DNA hypomethylation in multiple sclerosis diseaseHamid Zahednasab, Seyed Amir Bahreini
Journal of the Neurological Sciences|August 2, 2022
The enigmatic role of macrophage inhibitory factor (MIF) in the pathogenesis of multiple sclerosis (MS)Mohammad Hossein Harirchian, Hamid Zahednasab, Sajad Karampoor
Iranian Journal of Cancer Prevention|August 3, 2016
Nanocarriers Usage for Drug Delivery in Cancer TherapyHadi Khodabandehloo, Hamid Zahednasab, Asghar Ashrafi Hafez
Pageof 5

Showing results (1-10 of 44) with videos related to

Sort By:
Pageof 5
Neurology|July 3, 2013
Impairment of JCV-specific T-cell response by corticotherapy: effect on PML-IRIS management?Hamid Zahednasab
Neurology|November 7, 2012
Anti-JC Virus Antibodies in a Large German Natalizumab-Treated MS CohortHamid Zahednasab
Journal of Neuroimmunology|February 10, 2016
The correlation of HLA-G with multiple sclerosisHamid Zahednasab, Sajad Karampoor
International Journal of Biological Macromolecules|October 8, 2025
Molecular interplay between oxidative and endoplasmic reticulum stress in multiple sclerosisMaryam Kamarehei, Hamid Zahednasab
Neuropeptides|June 22, 2025
Neuroprotective effect of Ac-SDKP peptide in SH-SY5Y cells and rat model of Parkinson's disease against 6-OHDA-induced oxidative stress and ER stressMaryam Kamarehei, Hamid Zahednasab
Gene|July 12, 2014
The role of miR-326 and miR-26a in MS disease activityHamid Zahednasab, Mohammad Balood
Annals of Neurology|March 19, 2011
Interferon-beta and toll-like receptor-9 processingHamid Zahednasab, Seyed Amir Bahreini
Journal of the Neurological Sciences|March 16, 2010
DNA hypomethylation in multiple sclerosis diseaseHamid Zahednasab, Seyed Amir Bahreini
Journal of the Neurological Sciences|August 2, 2022
The enigmatic role of macrophage inhibitory factor (MIF) in the pathogenesis of multiple sclerosis (MS)Mohammad Hossein Harirchian, Hamid Zahednasab, Sajad Karampoor
Iranian Journal of Cancer Prevention|August 3, 2016
Nanocarriers Usage for Drug Delivery in Cancer TherapyHadi Khodabandehloo, Hamid Zahednasab, Asghar Ashrafi Hafez
Pageof 5